JPRN-UMIN000007432已完成未知
Prospective research of infliximab treatment in active RA patients refractry to anti-interleukin six receptor monoclonal antibody. - PRISM Study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patient has received IFX in the past. During a TCZ washout period, Patient treated of biologics and immunosuppressant which does not have adaptation of preparation or rheumatoid arthritis. Patient is contraindication of IFX and MTX.
研究者
相似试验
招募中
2 期
The feasibility study of accelated infliximab infusion from initial administratiopatient in whom infliximab is indicated(rheumatoid arthritis, Crohn's disease, Ulcerative colitis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis)JPRN-UMIN000015297Chiba University Hospital54
已完成
2 期
The feasibility study of accelated infliximab infusion during maintenance phasepatient in whom infliximab is indicated(rheumatoid arthritis, Crohn's disease, Ulcerative colitis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis)JPRN-UMIN000007806Chiba University Hospital54
已完成
不适用
Prospective Pilot study of Infliximab Dose-intensification determined by Capsule Endoscopic Evaluation of Small Intestinal Involvements in Patients with Crohn's Diseases diseaseCrohn's diseaseJPRN-UMIN000012790Saitama Medical center20
已完成
2 期
A study of infliximab administration method for tacrolimus-resistant active ulcerative colitisulcerative colitisJPRN-UMIN000013716Yokohama City University Medical Center40
已完成
Unknown
Study of Infliximab Therapy for Multiple Treatment(included IVIG)-resistant Kawasaki DiseaseKawasaki DiseaseJPRN-jRCT1091220201Investigator-initiated Clinical Research(in-house)20